|
|
|
Volumn 6, Issue 2, 1997, Pages 13-15
|
|
Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatment
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE THERAPY;
CARDIOVASCULAR DISEASE;
CONFERENCE PAPER;
ECHOCARDIOGRAPHY;
ELECTROCARDIOGRAPHY;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART LEFT VENTRICLE MASS;
HEART LEFT VENTRICLE PRESSURE;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PROGNOSIS;
RISK FACTOR;
HEART VENTRICLE;
HISTOLOGY;
ORGAN SIZE;
PATHOLOGY;
PATHOPHYSIOLOGY;
REVIEW;
ANTIHYPERTENSIVE AGENT;
ANTIHYPERTENSIVE AGENTS;
HEART VENTRICLES;
HUMANS;
HYPERTENSION;
HYPERTROPHY, LEFT VENTRICULAR;
ORGAN SIZE;
PROGNOSIS;
|
|
EID: 0031413706
PISSN: 08038023
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (11)
|
